Côte d'Ivoire vs Nepal: Access to anti-retroviral drugs, female
Côte d'Ivoire
84.0%
in 2024
Nepal
83.0%
in 2024
Côte d'Ivoire rank
50th
Nepal rank
53rd
Access to anti-retroviral drugs, female over time
- Côte d'Ivoire
- Nepal
How they compare
Côte d'Ivoire currently reports 84.0% against 83.0% in Nepal, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Nepal ahead.
Côte d'Ivoire ranks 50th and Nepal ranks 53rd of 141 countries.
Côte d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 2.8% | 2.0% | Côte d'Ivoire |
| 2010s | 41.6% | 35.5% | 6.1% | Côte d'Ivoire |
| 2020s | 78.2% | 72.8% | 5.4% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Côte d'Ivoire or Nepal?
- Côte d'Ivoire, at 84.0% against 83.0% in Nepal as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Côte d'Ivoire and Nepal?
- 1.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Nepal?
- 25 years are reported by both, from 2000 to 2024.
- How do Côte d'Ivoire and Nepal rank globally for access to anti-retroviral drugs, female?
- Côte d'Ivoire ranks 50th and Nepal ranks 53rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.